Germ cell tumor classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Blanked the page)
Tag: Blanking
 
(94 intermediate revisions by the same user not shown)
Line 1: Line 1:
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Types}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Subtypes}}
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF|Signs and Symptoms}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Histopathology}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Lab finding }}
! style="background: #4479BA; padding: 5px 5px;" colspan=1 | {{fontcolor|#FFFFFF| Treatment }}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Prognosis}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="3;"|Gonadal'''
| style="padding: 5px 5px; background: #F5F5F5;" |
Seminoma (Testis)
| style="padding: 5px 5px; background: #F5F5F5;" |
* Painless [[testicular mass]] with discomfort
* [[Back pain]]
* [[Abdominal discomfort]]
* [[Abdominal mass]].
| style="padding: 5px 5px; background: #F5F5F5;" |Gross: pale gray to yellow nodules that are uniform or slightly lobulated and often bulge from the cut surface
| style="padding: 5px 5px; background: #F5F5F5;" |
* Complete blood count and blood chemistry tests.
* Abnormal serum tumor marker levels ([[LDH]], [[HCG]]).<ref name="Diagnosisoftesticularcancer1" />
* CT: Metastases to the para-aortic, inguinal, or iliac lymph nodes. Visceral metastasis may also be seen.
* Pelvic MRI: may be diagnostic. multinodular tumors of uniform signal intensity
* Hypo- to isointense on T2-weighted images and inhomogenous enhancement on contrast enhanced T1-weighted images.
* Other diagnostic studies for seminoma include [[biopsy]], [[PET|FDG-PET scan]], and [[bone scan]].
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Orchiectomy|Radical inguinal orchiectomy]] is the first treatment for any stage of testicular seminoma. Usually done as diagnostic and therapeutic.
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Prognosis]] of [[seminoma]] is good for all stages with greater than 90% cure rate.
* The International Germ Cell Cancer Consensus Group divides [[seminoma]] into two prognosis groups: good and intermediate.
* Common complications of [[seminoma]] include recurrence, [[lymph node]] [[metastasis]], distant [[metastasis]], and secondary [[malignancies]].
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
Dysgerminoma


(Ovarian germ cell tumor)
| style="padding: 5px 5px; background: #F5F5F5;" |
* Depend on the type of the [[tumor]] and its potential to produce [[hormonal]]<nowiki/>materials
* [[Abdominal pain]] or distention
* [[Menstrual irregularities]]
* Symptoms of [[virilization]]
* Rapidly growing [[abdominal]]/[[pelvic]] [[mass]]
* [[Acute abdominal pain]] from [[complications]] such as:
* *  [[Necrosis]]
* * [[Capsule|Capsular]] distention
* [[Rupture|* Rupture]] or [[torsion]] and or simply they can be [[asymptomatic]].
| style="padding: 5px 5px; background: #F5F5F5;" |
*The majority of [[ovarian]] [[germ cell]][[tumors]] have a [[solid]] and [[cystic]] appearance with areas of [[hemorrhage]]<nowiki/>and [[necrosis]]
* A uniform “fried egg” appearance ([[dysgerminoma]])
| style="padding: 5px 5px; background: #F5F5F5;" |
*Beta-hCG to rule out pregnancy in women with abdominopelvic symptoms
*Cultures for gonorrhea and chlamydia and a wet mount in reproductive and sexually active women to role out and treat before surgery if positive.
*Lactate dehydrogenase (LDH), alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (beta-hCG) levels. If any levels are elevated, they may assist in diagnosis and/ or follow-up of women diagnosed with malignant ovarian GCTs.
*Inhibin A and B
*Cancer antigen 125 (CA-125) - For epithelial tumors
*Ultrasound: Dysgerminoma often appears as a [[Echogenicity|hypoechoic]] [[mass]]
*
*
*
| style="padding: 5px 5px; background: #F5F5F5;" |
* Chemotherapy: except those with stage 1a, stage 1a, 1b [[dysgerminoma]]
* Radiotherapy:
<nowiki>**</nowiki>  [[Dysgerminoma]] is radiosensitive.
[[Radiotherapy|** Radiotherapy]] is not anymore the first option of treatment for [[dysgerminoma]] considering its association with [[ovarian failure]]<nowiki/>development.
* Surgery: for diagnostic grading and therapy depending on if the patient prefers to preserve the ovary or not.
<br />
| style="padding: 5px 5px; background: #F5F5F5;" |
* The 5-year [[survival rate]] of the patient even with [[Disseminated disease|disseminated]][[dysgerminoma]] at the time of [[diagnosis]] is above 90%.
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
Germinoma (Brain)
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="6;" | Extragonadal
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"| Embryonic
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*
|-
| style="padding: 5px 5px; background: #F5F5F5;" | 
Teratoma
| style="padding: 5px 5px; background: #F5F5F5;" |
* [[Chest pain]]
* [[Cough]]
* [[Shortness of breath]]
* [[Abdominal pain]]
* [[Lump]], Abdominal(ovarian teratoma)
* Abnormal [[bleeding]] from the vagina
* [[Fatigue]], [[weight loss]]
* Limited ability to tolerate exercise
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" rowspan="1;"|
Extraembryonic
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
Coriocarcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
| style="padding: 5px 5px; background: #F5F5F5;" |
Yolk sac tumor
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
|-
|}
<references />

Latest revision as of 14:23, 23 September 2019